These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29104285)

  • 1. The atopic dermatitis market.
    Pantazi E; Valenza G; Hess M; Hamad B
    Nat Rev Drug Discov; 2018 Apr; 17(4):237-238. PubMed ID: 29104285
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemokine neutralization as an innovative therapeutic strategy for atopic dermatitis.
    Abboud D; Hanson J
    Drug Discov Today; 2017 Apr; 22(4):702-711. PubMed ID: 27956056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APT drug R&D: the right active ingredient in the right presentation for the right therapeutic use.
    Cavalla D
    Nat Rev Drug Discov; 2009 Nov; 8(11):849-53. PubMed ID: 19713959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repackaging.
    Prescrire Int; 2016 Jan; 25(167):10. PubMed ID: 26942252
    [No Abstract]   [Full Text] [Related]  

  • 5. Mergers in Japan help firms retain own products.
    Fuyuno I
    Nat Rev Drug Discov; 2005 May; 4(5):358. PubMed ID: 15902766
    [No Abstract]   [Full Text] [Related]  

  • 6. Good pharma, bad pharma.
    Drug Ther Bull; 2013 Aug; 51(8):85. PubMed ID: 23927857
    [No Abstract]   [Full Text] [Related]  

  • 7. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.
    Bieber T
    Nat Rev Drug Discov; 2022 Jan; 21(1):21-40. PubMed ID: 34417579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Government action needed to step up research and development for world's most neglected diseases.
    Pecoul B
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495
    [No Abstract]   [Full Text] [Related]  

  • 9. Wrong questions, wrong answers? Are we getting the drugs we need?
    Lipworth WL; Kerridge IH; Day RO
    Clin Pharmacol Ther; 2012 Mar; 91(3):367-9. PubMed ID: 22343808
    [No Abstract]   [Full Text] [Related]  

  • 10. Redesigner drugs.
    Dove A
    Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Market watch: pricing strategies for emerging markets.
    Lineberry N; Snyder E; Gunda S
    Nat Rev Drug Discov; 2011 Aug; 10(8):567. PubMed ID: 21804586
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of drug manufacturers' patient assistance programs by safety net providers.
    Richardson K; Basskin LE
    Am J Health Syst Pharm; 2002 Jun; 59(11):1105-9. PubMed ID: 12063897
    [No Abstract]   [Full Text] [Related]  

  • 13. Socioeconomics of atopic dermatitis-can we afford new treatments?
    Blaiss MS
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):355-357. PubMed ID: 30036582
    [No Abstract]   [Full Text] [Related]  

  • 14. Market watch: Top drugs and companies by sales in 2017.
    Urquhart L
    Nat Rev Drug Discov; 2018 Mar; 17(4):232. PubMed ID: 29588516
    [No Abstract]   [Full Text] [Related]  

  • 15. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 17. Resurrection men dig through the drug graveyard: ARYx revives problem blockbuster drugs.
    Wolfson W
    Chem Biol; 2005 Nov; 12(11):1155-6. PubMed ID: 16298292
    [No Abstract]   [Full Text] [Related]  

  • 18. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 19. The default of 1998 and pharmaceutical market. Report I. The chronicle of disaster.
    Zatravkin SN; Ignatiev VG; Vishlenkova EA
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2022 Jul; 30(4):683-691. PubMed ID: 35960302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Market watch: Specialty pharmaceuticals to provide majority of sales by 2012.
    Goodman M
    Nat Rev Drug Discov; 2009 Mar; 8(3):184. PubMed ID: 19247297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.